ACTG Presents Data Showing Minimal Monitoring Approach to Hepatitis C Treatment is Safe and Successful at AASLD’s 2020 Liver Meeting

Nov 16, 2020

The AIDS Clinical Trials Group (ACTG), the world’s largest and longest established HIV research network, presented today The “Keep it Simple and Safe” Approach to HCV Treatment: Primary Outcomes from the ACTG A5360 (MINMON) Study at AASLD’s virtual 2020 Liver Meeting. The study found that in a diverse, global patient population, a minimal monitoring (MINMON) approach to hepatitis C treatment was safe and achieved comparable sustained virologic response (SVR) to current standard of care. To read more click here.